Skip to main content

Find Clinical Trials

Home
Conditions
ANCA Associated Vasculitis

Clinical trial condition

ANCA Associated Vasculitis

Explore clinical trials studying ANCA Associated Vasculitis. Study availability and eligibility vary by location and protocol.

22 public trials 11 recruiting studies

Refine in advanced search Browse all conditions

ANCA Associated Vasculitis trial results

Recruiting

A Trial to Evaluate the Efficacy of Pioglitazone to Promote Renal Tolerance in ANCA-associated Vasculitis - RENATO Trial

NCT05946564

Conditions: ANCA Associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +10 more
Locations: CHU Amiens Amiens, France

CHU d'Angers Angers, France

CH de Boulogne sur Mer Boulogne-sur-Mer, France

CHU Brest - Hôpital de la Cavale Blanche Brest, France

View all 25 locations

View Trial Details

Recruiting

Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis

NCT07010250

Conditions: ANCA Associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +31 more
Locations: Georges-Pompidou European Hospital, AP-HP Paris, France

View Trial Details

Recruiting

EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases

NCT07077304

Conditions: ANCA Associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Aortic Arch Syndromes, +61 more
Locations: Assistance Publique Hôpitaux de Paris, Paris, île de France 75010 Paris, France

View Trial Details

Recruiting

Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases

NCT06548607

Conditions: ANCA Associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Arthritis, +31 more
Locations: The Third the People's Hospital of Bengbu Bengbu, Anhui, China

View Trial Details

Recruiting

A Study of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases.

NCT07203404

Conditions: ANCA Associated Vasculitis, ANCA-Associated Glomerulonephritis, Anti-GBM Disease, +27 more
Locations: Bioheng Study site Shanghai, China

View Trial Details

Recruiting

Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases

NCT06685042

Conditions: ANCA Associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +20 more
Locations: Fondazione Policlinico Universitario A. Gemelli IRCCS Rome, Lazio, Italy

View Trial Details

Recruiting

Early-access Avacopan in Real-world ANCA-associated Vasculitis

NCT06794827

Conditions: ANCA Associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +8 more
Locations: Leiden University Medical Center Leiden, Netherlands

View Trial Details

Recruiting

Neutrophil Extracellular Traps in Different Forms of Systemic Sclerosis

NCT06462768

Conditions: ANCA Associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +21 more
Locations: Chu Reims Reims, France

View Trial Details

Recruiting

Refractory ANCA Associated Vasculitis and Lupus Nephritis Treated With BCMA-targeting CAR-T Cells

NCT06277427

Conditions: ANCA Associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +19 more
Locations: Tongji Hospital Wuhan, Hubei, China

View Trial Details

Recruiting

Efficacy and Safety for Rituximab Combined With Telitacicept in the Treatment of ANCA-associated Vasculitis (TTCAAVREM)

NCT05962840

Conditions: ANCA Associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +8 more
Locations: Peking Union Medical College Hospital Beijing, China

View Trial Details